MINUCCI, SAVERIO
 Distribuzione geografica
Continente #
EU - Europa 5643
NA - Nord America 4919
AS - Asia 4252
SA - Sud America 228
OC - Oceania 184
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15284
Nazione #
US - Stati Uniti d'America 4720
CN - Cina 2976
GB - Regno Unito 2034
IT - Italia 948
DE - Germania 619
SE - Svezia 580
KR - Corea 273
JP - Giappone 225
IE - Irlanda 217
FR - Francia 188
TR - Turchia 186
CA - Canada 171
AU - Australia 169
UA - Ucraina 168
BR - Brasile 154
TW - Taiwan 137
NL - Olanda 125
RU - Federazione Russa 114
IN - India 110
ES - Italia 91
FI - Finlandia 89
BE - Belgio 88
EU - Europa 74
PL - Polonia 64
CH - Svizzera 61
DK - Danimarca 59
TH - Thailandia 44
HK - Hong Kong 41
SG - Singapore 41
GR - Grecia 37
AT - Austria 36
NO - Norvegia 36
CO - Colombia 35
MY - Malesia 34
VN - Vietnam 30
IR - Iran 26
ID - Indonesia 25
MX - Messico 23
PH - Filippine 23
PT - Portogallo 17
CL - Cile 15
CZ - Repubblica Ceca 15
NZ - Nuova Zelanda 15
RO - Romania 15
CY - Cipro 13
ZA - Sudafrica 12
PK - Pakistan 10
EC - Ecuador 9
ET - Etiopia 9
MO - Macao, regione amministrativa speciale della Cina 9
AE - Emirati Arabi Uniti 8
SI - Slovenia 7
EG - Egitto 6
NG - Nigeria 6
PE - Perù 6
AR - Argentina 5
HU - Ungheria 5
IL - Israele 5
JO - Giordania 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
IQ - Iraq 4
LB - Libano 4
MT - Malta 4
SA - Arabia Saudita 4
VE - Venezuela 4
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
HR - Croazia 3
LT - Lituania 3
MA - Marocco 3
BD - Bangladesh 2
BG - Bulgaria 2
CR - Costa Rica 2
EE - Estonia 2
IS - Islanda 2
KE - Kenya 2
KW - Kuwait 2
LU - Lussemburgo 2
MG - Madagascar 2
ML - Mali 2
MM - Myanmar 2
MU - Mauritius 2
RS - Serbia 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AP - ???statistics.table.value.countryCode.AP??? 1
AW - Aruba 1
BH - Bahrain 1
BT - Bhutan 1
CU - Cuba 1
GH - Ghana 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
NP - Nepal 1
SC - Seychelles 1
TN - Tunisia 1
Totale 15351
Città #
Southend 1715
Hangzhou 538
Beijing 532
Seattle 431
Chandler 342
Milan 322
Fairfield 235
Shanghai 231
Wilmington 227
Dublin 207
Princeton 200
Nanjing 199
Guangzhou 174
Dearborn 170
Redwood City 168
Houston 164
Ann Arbor 156
Ashburn 131
Jacksonville 129
Woodbridge 128
Taipei 98
Wuhan 98
Cambridge 96
Shenyang 89
Mountain View 79
Redmond 79
Des Moines 77
Changsha 75
Jinan 70
Seoul 67
Chengdu 66
Boise 58
Hanover 57
Sakarya 55
Tianjin 53
Phoenix 52
Boardman 50
Warsaw 49
Brussels 48
Zhengzhou 47
Toronto 46
Tokyo 44
Serra 41
Ottawa 40
Los Angeles 39
Nanchang 38
New York 38
Andover 36
Pittsburgh 36
Xian 35
London 34
Bogotá 33
Dallas 32
Istanbul 32
Somerville 32
Berlin 30
Changchun 30
Chongqing 28
Hebei 28
Rochester 28
Rome 27
Hefei 26
Evanston 24
Kunming 23
São Paulo 22
San Diego 21
Athens 20
Bangkok 20
Fuzhou 20
Sunnyvale 20
Birmingham 19
Boston 19
Atlanta 18
Harbin 18
Madrid 18
Chicago 17
Munich 17
Philadelphia 17
Durham 16
Oslo 16
Shenzhen 16
Suzhou 16
Turin 16
Bethesda 15
Central District 15
Columbus 15
Hanoi 15
Jiaxing 15
Singapore 15
Zurich 15
Amsterdam 14
Falls Church 14
Ningbo 14
Silver Spring 14
Taizhou 14
Barcelona 13
Düsseldorf 13
Melbourne 13
Montréal 13
Sydney 13
Totale 9148
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 3665
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer 1031
Blood orange juice inhibits fat accumulation in mice 760
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer 594
Entinostat for the treatment of breast cancer 470
Guidelines for the use and interpretation of assays for monitoring autophagy 430
Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors 364
Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner 328
A dual role for Hdac1 : oncosuppressor in tumorigenesis, oncogene in tumor maintenance 301
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 287
Differentiation response of acute promyelocytic leukemia cells and PML/RAR alpha leukemogenic activity studies by real-time RT-PCR 197
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis 184
Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis 183
Mechanisms of selective anticancer action of histone deacetylase inhibitors 175
Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity 165
Immunohistochemical detection of Ym1/Ym2 chitinase-like lectins associated with hyalinosis and polypoid adenomas of the transitional epithelium in a mouse with acute myeloid leukemia 161
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer 158
Pathology tissue-chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samples 157
Cinnamic anilides as new mitochondrial permeability transition pore inhibitors endowed with ischemia-reperfusion injury protective effect in vivo 150
Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples 147
MicroRNA-222 Regulates Melanoma Plasticity 143
New method to detect histone acetylation levels by flow cytometry 140
The methyl-CpG binding protein MBD1 is required for PML-RARα function 130
PAT-ChIP coupled with laser microdissection allows the study of chromatin in selected cell populations from paraffin-embedded patient samples 130
The DNA demethylating agent decitabine activates the TRAIL pathway and induces apoptosis in acute myeloid leukemia 125
NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation 118
Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach 114
Il succo di arancia rossa inibisce l’accumulo di grassi in modelli animali 113
Determinants of oncogenic transformation in acute promyelocytic leukemia : the hetero-union makes the force 111
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells 111
Retinoid X receptor-selective ligands produce malformations in Xenopus embryos 109
DNA Methyl-Transferase inhibitors and Histone De-Acetylases inhibitors contrast leukemias reactivating the same apoptosis pathways 107
PP2A Controls Genome Integrity by Integrating Nutrient-Sensing and Metabolic Pathways with the DNA Damage Response 107
Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice 104
Immunocell-array for molecular dissection of multiple signaling pathways in mammalian cells 102
Epigenomic profiling of cancer cells 102
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells 101
Common themes in the pathogenesis of acute myeloid leukemia 99
Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc 98
Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis 98
Impairment of p53 acetylation, stability and function by an oncogenic transcription factor 97
Assessment of histone acetylation levels in relation to cell cycle phase 97
Endosomal trafficking and DNA damage checkpoint kinases dictate survival to replication stress by regulating amino acid uptake and protein synthesis 97
The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells 94
Leukemia-associated fusion proteins : multiple mechanisms of action to drive cell transformation 89
MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function 88
HDACs link the DNA damage response, processing of double-strand breaks and autophagy 87
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway 86
Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO 86
Chromatin accessibility, p300 and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia 86
Chromatin immunoprecipitation and high-throughput sequencing from paraffin-embedded pathology tissue 85
Acetylation: a novel link between double-strand break repair and autophagy 82
Eosinophilic crystals as a distinctive morphologic feature of a hyaline droplet nephropathy in a mouse model of acute myelogenous leukaemia 82
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype 82
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation 82
Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein 81
Histone deacetylases and epigenetic therapies of hematological malignancies 79
Tranylcypromine Derivatives Useful as Inhibitors Demethylases LSD1 and LSD2 79
A redundant oncogenic potential of the retinoic receptor (RAR) alpha, beta and gamma isoforms in acute promyelocytic leukemia 76
The APL-associated fusion proteins 76
Redox-mediated suberoylanilide hydroxamic acid sensitivity in breast cancer 76
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras 75
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma 73
PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors 73
Epigenomic profiling of archived FFPE tissues by enhanced PAT-ChIP (EPAT-ChIP) technology 71
Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation 69
The International Human Epigenome Consortium : A Blueprint for Scientific Collaboration and Discovery 68
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells 67
Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence 67
In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue 66
Dual modulation of MCL-1 and mTOR determines the response to sunitinib 65
Retinoid receptors in health and disease: co-regulators and the chromatin connection 63
Molecular and biological analysis of histone deacetylase inhibitors with diverse specificities 63
BLUEPRINT to decode the epigenetic signature written in blood 63
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors 63
Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias? 62
Targeting protein inactivation through an oligomerization chain reaction 62
The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha 62
Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia 58
PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage 58
Spiro[chromane-2,4'-piperidine]-based histone deacetylase inhibitors with improved in vivo activity 58
Discovery, synthesis, and pharmacological evaluation of spiropiperidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors 58
Self-renewal of tumor cells : Epigenetic determinants of the cancer stem cell phenotype 56
Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia 55
Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies 54
Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL 53
Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer 51
Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer 50
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 50
PML is required for telomere stability in non-neoplastic human cells 43
Molecular pathways: old drugs define new pathways: non-histone acetylation at the crossroads of the DNA damage response and autophagy 40
Pharmacokinetic drug evaluation of ribociclib for the treatment of metastatic, hormone-positive breast cancer 40
Erratum: PML is required for telomere stability in non-neoplastic human cells (vol 35, pg 1811, 2016) 38
Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside 34
Extensive and systematic rewiring of histone post-translational modifications in cancer model systems 33
Anticancer innovative therapy congress: Highlights from the 10th anniversary edition 23
CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one- carbon metabolism in breast cancer 22
CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one- carbon metabolism in breast cancer 14
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML 14
LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response 14
Totale 16004
Categoria #
all - tutte 23210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018149 0000 00 00 000149
2018/20192549 415217187190 131192 296145 207174197198
2019/20202650 258120127228 225300 272180 327278186149
2020/20212391 15023217898 193205 190133 291212319190
2021/20221956 150125119167 159175 162154 204136160245
2022/20232353 264198190310 279429 141119 19810310616
Totale 16060